Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: A novel pH- and glutathione-responsive drug delivery system based on in situ growth of MOF199 on mesoporous organic silica nanoparticles targeting the hepatocellular carcinoma niche

Fig. 3

Uptake of drug-loaded nanocomposites. A The cellular internalization of PBS (a), MONs@MOF-199 (b), free DOX/SOR (c), D/S@MM (d), and D/S@SPMM (e) were monitored using CLSM after treatment with HepG2 cells for 4 h; scale bar is 100 µm. B Bio-TEM of blank control group (a-c) and D/S@SPMM nanocomposites experimental group (d-f). EDS analysis of D/S@SPMM (g-i)

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us